Cecilie Soma N.
- Country
- Norway
- Department
- oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 24 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in the treatment of HER2-positive breast cancer, with particular emphasis on innovative therapeutic approaches for non-metastatic cases.
- Targeted Therapy Development
- Neoadjuvant Treatment Strategies
- Molecular Classification
The investigator focuses on evaluating novel therapeutic agents for breast cancer treatment, particularly in the context of HER2-enriched subtypes.
Precision Medicine
The investigator explores biology-driven treatment selection approaches, emphasizing personalized therapeutic strategies based on molecular characteristics.
- Molecular Profiling
- Biomarker Analysis
- Treatment Response Assessment
Their work involves the evaluation of pathologic complete remission as a key outcome measure in breast cancer therapy.
Therapeutic Innovation
The investigator studies advanced therapeutic agents, including antibody-drug conjugates in breast cancer treatment.
- Novel Treatment Modalities
- Comparative Treatment Efficacy
- Clinical Response Evaluation
Their research encompasses the assessment of standard therapy approaches versus innovative treatment options in early-stage breast cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.